Chronic Iron Overload Clinical Trial
Official title:
A Prospective Non-interventional Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload
This is a prospective, multicenter, non-interventional study. Findings are analyzed using epidemiological methods.
This NIS shall document the therapy of chronic iron overload in a broad patient population with either of the approved iron chelators in Germany. The choice of patients and the therapy according to the SmPC follows the clinical routine exclusively. The regular observation time per patient is 24 months. Corresponding to the clinical routine, follow up visits can be documented after approximately 1, 3, 6, 9, 12 and 18 month with a close out visit after 24 month. In case the iron chelator is switched, the visit scheme should be passed through once again. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01825512 -
Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients
|
Phase 3 | |
Completed |
NCT06215287 -
Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials
|
||
Completed |
NCT01740713 -
Pharmacokinetic Study of Deferiprone in Paediatric Patients
|
Phase 2 | |
Completed |
NCT02720536 -
Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation
|
Phase 3 |